{
  "id": "mhgap#screening_cues_fee1864f",
  "content": "feedback from international experts and health workers implementing WHO’s Intersectoral global action plan\nwho are familiar with using the mhGAP guideline. This on epilepsy and other neurological disorders 2022–2031\ninformation will be used to evaluate the effects of the (3), the Global action plan on the public health response\nguideline on processes and health outcomes and to to dementia 2017–2025 (15) and the Global alcohol\nensure the quality of the guideline and identify areas to action plan 2022–2030 (16).\nbe improved. This will draw on existing WHO resources\n113\n6. Updating the evidence\nThe guideline will be updated five years after or a change in the published recommendation may\npublication. The WHO Steering Group will continue be warranted, respectively. Following publication and\nto follow the research developments in the mhGAP dissemination of the guideline, any concern about\nmodule areas, particularly those questions for which no validity of any recommendation would be promptly\nevidence was found and those that were supported by communicated to the guideline implementers in\nlow-certainty evidence, where new recommendations addition to plans to update the recommendation.\n114\nReferences\n1. Global burden of disease 2019: mental disorders 8. Dua T, Barbui C, Patel AA, Tablante EC, Thornicroft",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "screening_cues",
      "referral",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues feedback from international experts and health workers implementing WHO’s Intersectoral global action plan\nwho are familiar with using the mhGAP guideline. This on epilepsy and other neurological disorders 2022–2031\ninformation will be used to evaluate the effects of the (3), the Global action plan on the public health response\nguideline on processes and health outcomes and to to dementia 2017–2025 (15) and the Global alcohol\nensure the quality of the guideline and identify areas to action plan 2022–2030 (16).\nbe improved. This will draw on existing WHO resources\n113\n6. Updating the evidence\nThe guideline will be updated five years after or a change in the published recommendation may\npublication. The WHO Steering Group will continue be warranted, respectively. Following publication and\nto follow the research developments in the mhGAP dissemination of the guideline, any concern about\nmodule areas, particularly those questions for which no validity of any recommendation would be promptly\nevidence was found and those that were supported by communicated to the guideline implementers in\nlow-certainty evidence, where new recommendations addition to plans to update the recommendation.\n114\nReferences\n1. Global burden of disease 2019: mental disorders 8. Dua T, Barbui C, Patel AA, Tablante EC, Thornicroft Feedback from international experts and health workers implementing who’s intersectoral global action plan\nwho are familiar with using the mhgap guideline. this on epilepsy and other neurological disorders 2022–2031\ninfo..."
}